You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma
|
|---|---|
| Published in |
BMC Pulmonary Medicine, February 2011
|
| DOI | 10.1186/1471-2466-11-14 |
| Pubmed ID | |
| Authors |
Joseph M Parker, Chad K Oh, Craig LaForce, S David Miller, David S Pearlman, Chenxiong Le, Gabriel J Robbie, Wendy I White, Barbara White, Nestor A Molfino, the MEDI-528 Clinical Trials Group |
| Abstract |
Interleukin-9 (IL-9)-targeted therapies may offer a novel approach for treating asthmatics. Two randomized placebo-controlled studies were conducted to assess the safety profile and potential efficacy of multiple subcutaneous doses of MEDI-528, a humanized anti-IL-9 monoclonal antibody, in asthmatics. |
Mendeley readers
The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 6% |
| Denmark | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 101 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 19 | 17% |
| Student > Bachelor | 14 | 13% |
| Researcher | 11 | 10% |
| Student > Ph. D. Student | 10 | 9% |
| Student > Postgraduate | 8 | 7% |
| Other | 28 | 26% |
| Unknown | 19 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 36 | 33% |
| Agricultural and Biological Sciences | 14 | 13% |
| Biochemistry, Genetics and Molecular Biology | 5 | 5% |
| Immunology and Microbiology | 5 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
| Other | 22 | 20% |
| Unknown | 23 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2022.
All research outputs
#7,436,785
of 23,392,375 outputs
Outputs from BMC Pulmonary Medicine
#590
of 1,977 outputs
Outputs of similar age
#38,778
of 109,873 outputs
Outputs of similar age from BMC Pulmonary Medicine
#4
of 4 outputs
Altmetric has tracked 23,392,375 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 1,977 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 109,873 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.